Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-045948

Chief Medical Officer sold 58,261 shares at an average $54.04 ($3,148,172)

  • Chief Medical Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Detke Michael J. Chief Medical Officer 2021-07-06 Option exercise +12,600 $2.23 $28,098 40,861 D: show line 1 in the form
Detke Michael J. Chief Medical Officer 2021-07-06 Sale −32,313 $53.43 $1,726,484 8,548 D: show line 2 in the form
Detke Michael J. Chief Medical Officer 2021-07-06 Sale −8,260 $53.91 $445,297 288 D: show line 3 in the form
Detke Michael J. Chief Medical Officer 2021-07-06 Sale −288 $55.01 $15,843 0 D: show line 4 in the form
Detke Michael J. Chief Medical Officer 2021-07-07 Option exercise +17,400 $2.23 $38,802 17,400 D: show line 5 in the form
Detke Michael J. Chief Medical Officer 2021-07-07 Sale −3,934 $53.24 $209,446 13,466 D: show line 6 in the form
Detke Michael J. Chief Medical Officer 2021-07-07 Sale −1,648 $54.37 $89,602 11,818 D: show line 7 in the form
Detke Michael J. Chief Medical Officer 2021-07-07 Sale −4,353 $55.38 $241,069 7,465 D: show line 8 in the form
Detke Michael J. Chief Medical Officer 2021-07-07 Sale −6,942 $56.27 $390,626 523 D: show line 9 in the form
Detke Michael J. Chief Medical Officer 2021-07-07 Sale −523 $56.99 $29,806 0 D: show line 10 in the form
Open-market sales · 58,261 sh · avg $54.04 · $3,148,172

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Detke Michael J. Chief Medical Officer 2021-07-06 Option exercise · Stock Option (right to buy) −12,600 119,752 D: show line 11 in the form
Detke Michael J. Chief Medical Officer 2021-07-07 Option exercise · Stock Option (right to buy) −17,400 102,352 D: show line 12 in the form
Loading xslF345X03/doc4.xml…